The role of cholesterol in prostate cancer

被引:141
作者
Hager, Martin H.
Solomon, Keith R.
Freeman, Michael R.
机构
[1] Childrens Hosp, Enders Res Labs, Dept Orthopaed Surg, Boston, MA 02115 USA
[2] Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA 02115 USA
关键词
cell signaling; cholesterol; lipid rafts; prostate cancer;
D O I
10.1097/01.mco.0000232896.66791.62
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose of review Experimental and epidemiological evidence suggests that cholesterol may play a promotional role in prostate cancer development and progression. This review seeks to provide an overview of established links between cholesterol and prostate cancer, with an emphasis on very recent scientific contributions supporting a role of cholesterol in prostate cancer etiology. Recent findings Elevated cholesterol levels in prostate cancer cells have been found to result from aberrant regulation of cholesterol metabolism. Recent studies have identified Akt/protein kinase B and sterol response element binding proteins as major players regulating cholesterol biosynthesis and feedback regulation. It has also become apparent that prostate cancer cells process critical cell survival cues via specialized membrane microdomains that are dependent I on cholesterol for signal transduction. These findings converge to support a scenario in which abnormal cholesterol metabolism influences signal transduction events at the membrane in a manner that promotes tumor cell growth, inhibits apoptotic signals and potentially stimulates other malignant cellular behaviors. Summary Recent experimental evidence has invigorated the discussion of a role for cholesterol in prostate cancer. The identification of cholesterol as a critical component in signal transduction events in prostate cancer cells has not only provided new mechanistic insights but also opened up new avenues for chemotherapeutic intervention.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 60 条
[1]
Fatty acid synthase: A metabolic oncogene in prostate cancer? [J].
Baron, A ;
Migita, T ;
Tang, D ;
Loda, M .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (01) :47-53
[2]
BERTRAM J, 2006, PROSTATE 0222
[3]
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer -: A nested case-control study [J].
Blais, L ;
Desgagné, A ;
LeLorier, J .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (15) :2363-2368
[4]
The androgen receptor and prostate cancer invasion [J].
Bonaccorsi, L ;
Muratori, M ;
Marchiani, S ;
Forti, G ;
Baldi, E .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 246 (1-2) :157-162
[5]
BRAVI F, 2006, ANN ONCOL 0412
[6]
Detergents as tools for the purification and classification of lipid rafts [J].
Chamberlain, LH .
FEBS LETTERS, 2004, 559 (1-3) :1-5
[7]
Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO
[8]
2-2
[9]
Statins and cancer risk - A meta-analysis [J].
Dale, KM ;
Coleman, CI ;
Henyan, NN ;
Kluger, J ;
White, CM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :74-80
[10]
Regulation of transbilayer plasma membrane phospholipid asymmetry [J].
Daleke, DL .
JOURNAL OF LIPID RESEARCH, 2003, 44 (02) :233-242